Aortic valve stenosis and coronary artery disease: Pathophysiological and clinical links

Journal of Cardiovascular Medicine

Volumn 8, Issue 12, 2007, Pages 983-989

  Mazzone, Annamaria ^a   Venneri, Lucia ^b   Berti, Sergio ^a  

^a G PASQUINUCCI HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Aortic valve sclerosis; Atherosclerosis; Calcified aortic valve stenosis; Cardiovascular risk factors; Coronary artery disease; Inflammation

Indexed keywords

CHOLESTEROL;

AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIUM LESION; HEREDITY; HUMAN; HYPERTENSION; INFLAMMATION; OXIDATION; PATHOPHYSIOLOGY; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; TISSUE INJURY; CALCINOSIS; HOSPITALIZATION;

AORTIC VALVE STENOSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; HUMANS; INFLAMMATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 38449109007     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32802e6c3d     Document Type: Review

References (47)

1. Lindroos M, Kupari M, Heikkila J, Tuilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21:1220-1226.
2. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630-634.
3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341:142-147.
4. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59:998-999.
5. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? A clinical morphologic study. Clin Cardiol 1991; 14:995-999.
6. Aronow WS, Ahn C, Shirani J, Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999; 83:599-600.
7. Chandra HR, Goldstein JA, Choudhary N, Neill CS, George PB, Gangasani SR, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004; 43:169-175.
8. Olsen MH, Wachtell K, Bella JN, Gerdts E, Palmieri V, Nieminen MS, et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE sub study). Am J Cardiol 2005; 95:132-136.
9. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, et al. Mitral anular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke 2005; 36:2533-2537.
10. Barasch E, Gottdiener JS, Larsen MEK, Chaves PH, Newman AB. Cardiovascular morbidity and mortality in community - dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis. Am J Cardiol 2006; 97:1281-1286.
11. Agmon Y, Khandheria BK, Meissner I, Sicks JR, O'Fallon WM, Wiebers DO, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insight from a population-based study. J Am Coll Cardiol 2001; 38:827-834.
12. Novaro GM, Aronow HD, Mayer-Sabik E, Griffin BP. Plasma homocysteine and calcific aortic valve disease. Heart 2004; 90:802-803.
13. Agmon Y, Khandheria BK, Jamil T, Seward JB, Sicks JD, Fought AJ, et al. Inflammation, infection, and aortic valve sclerosis: insights from the Olmstead County (Minnesota) population. Atherosclerosis 2004; 174:337-342.
14. Galante A, Pietroiusti A, Vellini M, Piccolo P, Possati G, De Bonis M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001; 38:1078-1082.
15. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003; 41:136-141.
16. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90:844-853.
17. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
18. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279:1477-1482.
19. Fuster V, Stein B, Badimon L, Badimon JJ, Ambrose JA, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82:II47-II59.
20. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90:775-778.
21. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92:1084-1088.
22. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82:II38-II46.
23. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 45:1585-1593.
24. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772.
25. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343:1139-1147.
26. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168.
27. Sanchez PL, Santos JL, Kaski JC, Cruz I, Arribas A, Villacorta E, et al., for the Grupo AORTICA (Grupo de Estudio de la Estenosis Aortica). Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006; 97:90-93.
28. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. The risk of the development of aortic stenosis in patients with 'benign' aortic valve thickening. Arch Intern Med 2002; 162:2345-2234.
29. Faggiano P, Ghizzoni G, Sorgato A, Sabatini T, Simoncelli U, Gardini A, Rusconi C. Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992; 70:229-233.
30. Faggiano P, Antonini-Canterin F. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol 2003; 91:99-101.
31. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG, Achenbach S. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104:1927-1932.
32. Takasu J, Shavelle DM, O'Brien KD, Babaei A, Rosales J, Mao S, et al. Association between progression of aortic valve calcification and coronary calcification: assessment by electron beam tomography. Acad Radiol 2005; 12:298-304.
33. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611-617.
34. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, et al. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J 2004; 25:199-205.
35. Filsoufi F, Aklog L, Adams DH, Byrne JG. Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting. J Heart Valve Dis 2002; 1:S45-S49.
36. Mazzone A, Epistolato MC, De Caterina R, Storti S, Vittorini S. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol 2004; 43:1670-1676.
37. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Rydén L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in non rheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23:1162-1170.
38. Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke 2002; 33:1214-1219.
39. Mazzone A, Epistolato MC, Gianetti J, Castagnini M, Sassi C, Ceravolo R, et al. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease? Am J Clin Pathol 2006; 126:494-502.
40. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001; 85:601-602.
41. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes the development of calcific aortic valve stenosis. Heart 2001; 85:635-638.
42. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92:2163-2168.
43. Mohler ERI, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997; 17:547-552.
44. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95:197-202.
45. Otto CM. Why is aortic sclerosis associated with adverse clinical outcomes? J Am Coll Cardiol 2004; 43:176-178.
46. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40:1723-1730.
47. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104:2205-2209.